---
title: "Teva Pharmaceutical Industries (TEVA.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TEVA.US/norm.md"
symbol: "TEVA.US"
name: "Teva Pharmaceutical Industries"
parent: "https://longbridge.com/en/quote/TEVA.US.md"
datetime: "2026-05-20T19:27:23.310Z"
locales:
  - [en](https://longbridge.com/en/quote/TEVA.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TEVA.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TEVA.US/norm.md)
---

# Teva Pharmaceutical Industries (TEVA.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.3100 | 0.4086 | 0.3700 | 0.2400 | 0.1800 |
| ROE | 18.29% | 25.33% | 24.61% | 17.24% | 14.71% |
| Revenue | 3.98B | 4.71B | 4.48B | 4.18B | 3.89B |
| Net income | 369.00M | 480.00M | 433.00M | 282.00M | 214.00M |
| Operating income | 763.00M | 1.28B | 1.07B | 894.00M | 709.00M |
| Gross margin | 49.50% | 56.36% | 51.43% | 50.34% | 48.24% |
| Net margin | 9.27% | 10.19% | 9.67% | 6.75% | 5.50% |
| Profit quality | -1907.50% | 110.97% | 288.89% | 393.83% | -675.24% |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 40.04B | 40.75B | 39.86B | 40.13B | 38.41B |
| Leverage | 4.86 | 5.15 | 5.49 | 5.87 | 6.13 |
| BVPS | 7.07 | 6.88 | 6.32 | 5.95 | 5.46 |
| Turnover | 0.4423 | 0.4311 | 0.4111 | 0.4082 | 0.4093 |
| Cash & STI | 3.74B | 3.56B | 2.20B | 2.16B | 1.70B |
| Inv & Rec | 3.18B | 3.18B | 3.32B | 3.50B | 3.25B |
| LT assets | 4.33B | 4.42B | 5.16B | 5.17B | 4.99B |
| Net debt | 13.18B | 13.67B | 14.89B | 15.38B | 15.24B |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -40.00M | 1.16B | 369.00M | 227.00M | -105.00M |
| Investing CF | 229.00M | 165.00M | 135.00M | 236.00M | 201.00M |
| Financing CF | 13.00M | 40.00M | -453.00M | 6.00M | -1.74B |
| Free CF | 389.88M | 1.19B | 809.25M | 784.75M | -176.88M |
| OCF coverage | -20.94% | 815.49% | 62.86% | 9.47% | -7.02% |
| Repaid & issued | - | 0.0000 | - | 2.31B | - |
| CapEx | -168.00M | -142.00M | -136.00M | -96.00M | -127.00M |

## Distribution Plan

### Dividend History

| Description | Record Date | Ex-Date | Payment Date |
|-------------|-------------|---------|--------------|
| Cash Dividend: 
0.0722USD | 2017-11-28 | 2017-11-27 | 2017-12-12 |
| Cash Dividend: 
0.0722USD | 2017-08-29 | 2017-08-25 | 2017-09-14 |
| Cash Dividend: 
0.289USD | 2017-06-05 | 2017-06-01 | 2017-06-22 |